newsfilter
← Latest News
GlobeNewswire·

MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through innovative,